BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 18, 2009
View Archived Issues
Kenta Biotech Gets CHF12M for Anti-infective Antibodies
Kenta Biotech AG raised CHF12 million (US$10.1 million) in an internal Series B round that will fund the entry into the clinic of its second therapeutic antibody. (BioWorld International)
Read More
Cytos Shares Plunge on Hypertension Vaccine Miss
Read More
Scientists are Near Harnessing Power of Nanoparticles in Cancer
Read More
GW Pharma Hits the Mark in Phase III Sativex MS Trial
Read More
Stabilitech Bucks the Trend, Raises £3.3M for Technology
Read More
Europe's Biotech Firms Said to 'Face Catastrophe'
Read More
Shareholder Pressure Nixes Progen's Merger with Avexa
Read More
Roche, Genentech Finally Agree to Acquisition at $95 per Share
Read More
Other News To Note
Read More